TrialCancer causes & control : CCC2018

Prospective evaluation of serum IL-16 and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Amy Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.